Deal Area Analysis
Deals in the Pharmaceutical, Biotech and Speciality pharmaceutical industry relate to specific drug or technology developments in defined therapeutic areas. With over two thousand deals being signed each year since 2000, the complexity of deal-related data means that identifying the underlying trends in deal making for different sectors of the industry has become increasingly difficult.
A Deal Area Analysis provides a simple means by which to quickly gain an understanding of the changing dynamics in deal making within specific areas of the pharmaceutical and biotechnology industry. Using PharmaVentures proprietary intelligence resource, PharmaDeals Agreements, our analysts will identify any underlying trends in a client-specified data set and present the results in an easy to digest format.
